Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
about
Concepts and Controversies in Evaluating Vitamin K Status in Population-Based StudiesVascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein.Vitamin K Dependent Protection of Renal Function in Multi-ethnic Population Studies.The Role of Vitamin K in Chronic Aging Diseases: Inflammation, Cardiovascular Disease, and Osteoarthritis.Vitamin-K-Dependent Protection of the Renal Microvasculature: Histopathological Studies in Normal and Diseased Kidneys.Relationship Between Low Bone Mineral Density and Fractures With Incident Cardiovascular Disease: A Systematic Review and Meta-Analysis.The Role of Vitamin K Status in Cardiovascular Health: Evidence from Observational and Clinical Studies.Circulating Vitamin K Is Inversely Associated with Incident Cardiovascular Disease Risk among Those Treated for Hypertension in the Health, Aging, and Body Composition Study (Health ABC).Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients.Prevalence and Effects of Functional Vitamin K Insufficiency: The PREVEND Study.Effect of Vitamin K on Vascular Health and Physical Function in Older People with Vascular Disease--A Randomised Controlled Trial.Inactive Matrix Gla-Protein and Arterial Stiffness in Type 2 Diabetes Mellitus.Diabetes confers in vitro calcific potential on serum which associates with in vivo vascular calcification.Circulating desphospho-uncarboxylated matrix γ-carboxyglutamate protein and the risk of coronary heart disease and strokeCirculating osteogenic proteins are associated with coronary artery calcification and increase after myocardial infarction
P2860
Q26771243-BECCAADE-F42E-4E39-8B48-8B875FB3CF78Q33595040-D5A47E0F-DBED-4222-99B3-AEA480AE2056Q36645022-89F980AD-7682-42D1-B2BD-1966618BB96BQ37262329-0245DCE5-4F7C-47C6-9645-2E445B538FB3Q37315160-FA290575-A557-40F3-A21F-49A0C410D72DQ38764055-89A35D9D-6998-45F3-990F-EA8FF3180A6FQ41625344-9E11B8FB-BBA2-4D4C-AB66-F4D656AAC0CCQ46608099-B083891A-AE5D-4929-9AA8-DF280B60194EQ47230064-6444DD3C-AF92-4BAE-9BD9-74592719936BQ47239503-21733885-F9EA-4EE5-B68F-E21F5E976527Q48894187-A97883B7-6F91-43FE-A504-F633D06F9144Q51084400-794F3CFD-9D17-4CE7-82A8-7B789346EE16Q51093220-8C802B97-D8A7-4121-9B0C-AA5705A75A43Q57910034-A51458BB-B69D-4F1E-9FF7-E615591BA717Q58715301-9779EEF3-DC9F-4992-8D15-E4CD24760EAB
P2860
Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
@en
Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
@nl
type
label
Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
@en
Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
@nl
prefLabel
Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
@en
Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
@nl
P2093
P2860
P356
P1433
P1476
Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients.
@en
P2093
Elke J Magdeleyns
Geertje W Dalmeijer
Jolanda M A Boer
Joline W J Beulens
W M Monique Verschuren
P2860
P304
P356
10.2337/DC13-0065
P407
P577
2013-07-22T00:00:00Z